<bill session="115" type="h" number="1271" updated="2019-04-18T16:03:23Z">
  <state datetime="2017-03-01">REFERRED</state>
  <status>
    <introduced datetime="2017-03-01"/>
  </status>
  <introduced datetime="2017-03-01"/>
  <titles>
    <title type="official" as="introduced">To amend the Federal Food, Drug, and Cosmetic Act to prevent the abuse of dextromethorphan, and for other purposes.</title>
    <title type="short" as="introduced">DXM Abuse Prevention Act of 2017</title>
    <title type="short" as="introduced">DXM Abuse Prevention Act of 2017</title>
    <title type="display">DXM Abuse Prevention Act of 2017</title>
  </titles>
  <sponsor bioguide_id="J000292"/>
  <cosponsors>
    <cosponsor bioguide_id="C001067" joined="2018-06-05"/>
    <cosponsor bioguide_id="H000324" joined="2017-12-01"/>
    <cosponsor bioguide_id="K000188" joined="2017-11-13"/>
    <cosponsor bioguide_id="M001163" joined="2017-03-01"/>
    <cosponsor bioguide_id="M001181" joined="2017-11-13"/>
    <cosponsor bioguide_id="T000469" joined="2017-12-06"/>
  </cosponsors>
  <actions>
    <action datetime="2017-03-01">
      <text>Introduced in House</text>
    </action>
    <action datetime="2017-03-01" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
    <action datetime="2017-03-17">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
  </actions>
  <committees>
    <committee subcommittee="" code="HSIF" name="House Energy and Commerce" activity="Referral"/>
    <committee subcommittee="Health" code="HSIF14" name="House Energy and Commerce" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Child health"/>
    <term name="Civil actions and liability"/>
    <term name="Drug safety, medical device, and laboratory regulation"/>
    <term name="Drug trafficking and controlled substances"/>
    <term name="Drug, alcohol, tobacco use"/>
    <term name="Licensing and registrations"/>
    <term name="Prescription drugs"/>
    <term name="Retail and wholesale trades"/>
  </subjects>
  <amendments/>
  <summary date="2017-03-01T05:00:00Z" status="Introduced in House">DXM Abuse Prevention Act of 2017

This bill amends the Federal Food, Drug, and Cosmetic Act to: (1)&#160;require a retailer that sells&#160;certain drugs containing dextromethorphan (DXM) to have a verification system that is&#160;intended to ensure that no one under 18 years of age purchases such drugs from the retailer, (2)&#160;establish other restrictions on&#160;the sale of over-the-counter drugs containing DXM, and (3)&#160;establish restrictions on the distribution of bulk DXM.</summary>
  <committee-reports/>
</bill>
